skip to main content
Idioma:
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
1882PDComprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)
1882PDComprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1882PDComprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)

Battaglin, F ; Xiu, J ; Baca, Y ; Goldberg, R M ; Grothey, A ; Shields, A F ; Seeber, A ; Salem, M E ; Puccini, A ; Tokunaga, R ; Naseem, M ; Arai, H ; Wang, J ; Berger, M D ; Zhang, W ; Philip, P A ; Marshall, J L ; Korn, W M ; Lenz, H J

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Citações Citado por
2
Comprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)
Comprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)

Battaglin, F. ; Xiu, J. ; Baca, Y. ; Goldberg, R.M. ; Grothey, A. ; Shields, A.F. ; Seeber, A. ; Salem, M.E. ; Puccini, A. ; Tokunaga, R. ; Naseem, M. ; Arai, H. ; Wang, J. ; Berger, M.D. ; Zhang, W. ; Philip, P.A. ; Marshall, J.L. ; Korn, W.M. ; Lenz, H.J.

Annals of oncology, 2019-10, Vol.30, p.v764 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
3
1882PD - Comprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)
1882PD - Comprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

1882PD - Comprehensive molecular characterization of brain metastases (BM) from colorectal cancer (CRC)

Battaglin, F. ; Xiu, J. ; Baca, Y. ; Goldberg, R.M. ; Grothey, A. ; Shields, A.F. ; Seeber, A. ; Salem, M.E. ; Puccini, A. ; Tokunaga, R. ; Naseem, M. ; Arai, H. ; Wang, J. ; Berger, M.D. ; Zhang, W. ; Philip, P.A. ; Marshall, J.L. ; Korn, W.M. ; Lenz, H.J.

Annals of oncology, 2019-10, Vol.30, p.v764-v764 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Impact of global epigenetics machinery on clinical outcome of colorectal cancer patients treated with fluoropyrimidine-based therapy
Impact of global epigenetics machinery on clinical outcome of colorectal cancer patients treated with fluoropyrimidine-based therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of global epigenetics machinery on clinical outcome of colorectal cancer patients treated with fluoropyrimidine-based therapy

Fouad, M.A. ; Salem, S.E. ; Hussein, M. ; Zekri, A-R. ; Mohammed, D. ; Hafez, H. ; Shouman, S.

Annals of oncology, 2017-09, Vol.28, p.v602-v603 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
5
934P The TARGET study: A global investigation of advanced dosimetry for transarterial radioembolization of hepatocellular carcinoma with yttrium-90 glass microspheres
934P The TARGET study: A global investigation of advanced dosimetry for transarterial radioembolization of hepatocellular carcinoma with yttrium-90 glass microspheres
Material Type:
Artigo 		Adicionar ao Meu Espaço

934P The TARGET study: A global investigation of advanced dosimetry for transarterial radioembolization of hepatocellular carcinoma with yttrium-90 glass microspheres

Lam, M. ; Salem, R. ; Garin, E.

Annals of oncology, 2021-09, Vol.32, p.S820-S820 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
6
O-022A multi-institutional phase 2 study of single agent nivolumab in previously treated metastatic squamous cell carcinoma of the anal canal (SCCA)
O-022A multi-institutional phase 2 study of single agent nivolumab in previously treated metastatic squamous cell carcinoma of the anal canal (SCCA)
Material Type:
Artigo 		Adicionar ao Meu Espaço

O-022A multi-institutional phase 2 study of single agent nivolumab in previously treated metastatic squamous cell carcinoma of the anal canal (SCCA)

Morris, V ; Ciombor, K ; Salem, M ; Nimeiri, H ; Iqbal, S ; Singh, P ; Polite, B ; Deming, D ; Chan, E ; Wade, J ; Bekaii-Saab, T ; Wolff, R ; Eng, C

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii126-ii126 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
O-022 A multi-institutional phase 2 study of single agent nivolumab in previously treated metastatic squamous cell carcinoma of the anal canal (SCCA)
O-022 A multi-institutional phase 2 study of single agent nivolumab in previously treated metastatic squamous cell carcinoma of the anal canal (SCCA)
Material Type:
Artigo 		Adicionar ao Meu Espaço

O-022 A multi-institutional phase 2 study of single agent nivolumab in previously treated metastatic squamous cell carcinoma of the anal canal (SCCA)

Morris, V. ; Ciombor, K. ; Salem, M. ; Nimeiri, H. ; Iqbal, S. ; Singh, P. ; Polite, B. ; Deming, D. ; Chan, E. ; Wade, J. ; Bekaii-Saab, T. ; Wolff, R. ; Eng, C.

Annals of oncology, 2016-06, Vol.27, p.ii126 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
LBA21 Radioembolization with chemotherapy for colorectal liver metastases: A randomized, open-label, international, multicenter, phase III trial (EPOCH study)
LBA21 Radioembolization with chemotherapy for colorectal liver metastases: A randomized, open-label, international, multicenter, phase III trial (EPOCH study)
Material Type:
Artigo 		Adicionar ao Meu Espaço

LBA21 Radioembolization with chemotherapy for colorectal liver metastases: A randomized, open-label, international, multicenter, phase III trial (EPOCH study)

Mulcahy, M.F. ; Salem, R. ; Mahvash, A. ; Pracht, M. ; Montazeri, A.H. ; Bandula, S. ; Hermann, K. ; Brown, E. ; Zuckerman, D. ; Wilson, G. ; Kim, T-Y. ; Weaver, A. ; Ross, P. ; Harris, W.P. ; Johnson, M.S. ; Sofocleous, C.T. ; Padia, S.A. ; Lewandowski, R.J. ; Garin, E. ; Sinclair, P.

Annals of oncology, 2021-09, Vol.32, p.S1295-S1295 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma

Rohatiner, A.

Annals of oncology, 1994-05, Vol.5 (5), p.397-400 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
10
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?

Sabatier, R ; Eymard, J C ; Walz, J ; Deville, J L ; Narbonne, H ; Boher, J M ; Salem, N ; Marcy, M ; Brunelle, S ; Viens, P ; Bladou, F ; Gravis, G

Annals of oncology, 2012-03, Vol.23 (3), p.714 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.